Markedsdata leveret af TwelveData og Morningstar
IM Cannabis Corp. is an international medical cannabis company focused on importing, distributing, and selling cannabis-based products for medical patients in Israel and Germany. The company offers dried flower and full-spectrum cannabis extract products under brands including IMC, BLKMT, and LOT420, with a business model centered on regulated medical markets and pharmacy-based supply chains. Its operations include product sourcing, quality control, and market-specific distribution across Europe and the Middle East, supporting physicians, pharmacies, and patients who rely on standardized cannabis formulations. IM Cannabis Corp. also maintains an online and retail presence tied to its medical cannabis ecosystem, reinforcing its role as a specialized supplier within the healthcare and life sciences sectors. Headquartered in Kibbutz Glil-Yam, Israel, the company remains positioned as a focused participant in the growing regulated medical cannabis market.